ArticleIn vivo (Athens, Greece)

β-Blockers Reduced the Target Lesion Revascularization After Percutaneous Coronary Intervention Using an Everolimus-eluting Stent.

Tatsuya Fujinami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.